Illumina (ILMN -32.8%) is crushed following its Q3 warning. Citi, which smartly downgraded...

|By:, SA News Editor

Illumina (ILMN -32.8%) is crushed following its Q3 warning. Citi, which smartly downgraded shares in advance, is slashing its PT to $32, arguing Illumina's growth trajectory is now "called into question." Auriga is maintaining a Buy, citing Illumina's position in the next-gen DNA sequencing market. In addition to Life Sciences (LIFE -5.5% - previously), Affymetrix (AFFX -5.5%) is selling off on the news.